Portfolio Update

RNS Number : 7432E
Intl. Biotechnology Trust PLC
20 July 2016
 

INTERNATIONAL BIOTECHNOLOGY TRUST PLC

 

 

Portfolio Update as at 30 June 2016

 

 

Net Assets

£202m

Net Assets per share

532p

Share price

458p

Total value of unquoted investments

£24m

Total number of portfolio companies

86

 

Top Ten Holdings

 

Company Name

% NAV

Biogen

7.4

Celgene

6.7

Genmab

6.0

Regeneron

5.0

Amgen

4.4

Alexion

4.4

Vertex

3.5

Biomarin

3.2

Actelion

3.1

Intercept

2.9


-----------

Total

46.6

 

Geographical Allocation

% NAV

US & Canada

77

Europe & UK

23


-----------

Total

100

 

 

Quoted/Unquoted Allocation

% NAV

Quoted

89

Unquoted

11


-----------

Total

100

 

 

NAV % Market Cap

% NAV

Large Cap >USD10BN

68

Small Cap <USD1BN

26

Mid Cap =USD1-10BN

6


-----------

Total

100

 

 

NAV % by Therapeutic Areas

% NAV

Oncology

38

Orphan

20

CNS

10

Other

10

Inflammation

9

Ophthalmology

8

Medtech

5


-----------

Total

100

 

 

BNP Paribas Secretarial Services Limited

Company Secretary

 

20 JULY 2016


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFUBGGDRXDDBGLG
Investor Meets Company
UK 100

Latest directors dealings